We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Avigan

News List

Production of Avigan® Tablet (favipiravir) accelerated for use against COVID-19 europeanpharmaceuticalreview
April 20, 2020
FUJIFILM intends to accelerate production of Avigan to 100,000 treatment courses per month by July and up to 300,000 by September 2020 to meet demand for possible use treating COVID-19.
Fujifilm boosts production capacity for potential Covid-19 drug Avigan pharmaceutical-technology
April 17, 2020
Japan’s Fujifilm has expanded manufacturing capacity to boost production of its influenza drug Avigan (favipiravir), being assessed to potentially treat Covid-19.
Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients europeanpharmaceuticalreview
April 06, 2020
The developers of Avigan have increased production and announced a Phase III clinical trial testing its efficacy against COVID-19.
Chinese official says Fujifilm’s Favipiravir could treat Covid-19 pharmaceutical-technology
March 19, 2020
China’s Science and Technology Ministry official Zhang Xinmin has said that Japan-based Fujifilm’s anti-flu drug Favipiravir helped Covid-19 patients recover.

Previous page 1 2 Next page